Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Can Slow Breathing Reduce Hypertension in Women With Polycystic Ovary Syndrome?
EF 2018-19
Résumé
Polycystic ovary syndrome (PCOS) affects ~10% of premenopausal women in Canada. Most commonly associated with infertility, PCOS is diagnosed in women who meet two of the following criteria: high testosterone levels, irregular menstrual cycles, and polycystic ovaries. Women with this disorder may also be at risk for high blood pressure (BP). This is a concern given that even moderately high BP can predict poor cardiovascular outcomes including heart disease and stroke. Unfortunately, anti-hypertensive medications are not effective in all patients due to problems with compliance and drug resistance. As such, alternative treatments are needed to reduce BP in hypertensive individuals. Most notably, device-guided slow breathing has been recommended by the American Heart Association (AHA) as an alternative therapy to lower BP. Specifically, the AHA recommends the FDA-approved RESPeRATE device, which has been shown to decrease BP in men and postmenopausal women. However, no previous study has examined whether this intervention can decrease BP in women with PCOS. Therefore, this project will examine whether 8 weeks of device-guided slow breathing using the RESPeRATE device is effective in improving BP and other markers of cardiovascular health in women with PCOS. Participants will complete a 15-minute slow breathing session once per day. We hypothesize that after the 8 week intervention, participants will have lower resting BP and reduced breathing frequency. This study will provide preliminary evidence as to whether device-guided breathing can effectively reduce BP in women with PCOS.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
415330
Name
Jette Evan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Can Slow Breathing Reduce Hypertension in Women With Polycystic Ovary Syndrome?
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Baroreflex; Blood Pressure; Hypertension; Polycystic Ovary Syndrome; Resperate; Slow Breathing
Abstract
Polycystic ovary syndrome (PCOS) affects ~10% of premenopausal women in Canada. Most commonly associated with infertility, PCOS is diagnosed in women who meet two of the following criteria: high testosterone levels, irregular menstrual cycles, and polycystic ovaries. Women with this disorder may also be at risk for high blood pressure (BP). This is a concern given that even moderately high BP can predict poor cardiovascular outcomes including heart disease and stroke. Unfortunately, anti-hypertensive medications are not effective in all patients due to problems with compliance and drug resistance. As such, alternative treatments are needed to reduce BP in hypertensive individuals. Most notably, device-guided slow breathing has been recommended by the American Heart Association (AHA) as an alternative therapy to lower BP. Specifically, the AHA recommends the FDA-approved RESPeRATE device, which has been shown to decrease BP in men and postmenopausal women. However, no previous study has examined whether this intervention can decrease BP in women with PCOS. Therefore, this project will examine whether 8 weeks of device-guided slow breathing using the RESPeRATE device is effective in improving BP and other markers of cardiovascular health in women with PCOS. Participants will complete a 15-minute slow breathing session once per day. We hypothesize that after the 8 week intervention, participants will have lower resting BP and reduced breathing frequency. This study will provide preliminary evidence as to whether device-guided breathing can effectively reduce BP in women with PCOS.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jette, Evan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~